Charles River Laboratories International, Inc. (CRL): Revenue

Annual figures by period end, from SEC filings.

$4.02B
Year ended 2025-12-27
$4.00B
Trailing 12 months to 2026-06-27
+0.3%
3-year compound annual growth
+6.5%
5-year compound annual growth
+11.4%
10-year compound annual growth
$4.13B2008-12-27: $1.30B2009-12-26: $1.17B2010-12-25: $1.13B2011-12-31: $1.14B2012-12-29: $1.13B2013-12-28: $1.17B2014-12-27: $1.30B2015-12-26: $1.36B2016-12-31: $1.68B2017-12-30: $1.86B2018-12-29: $2.27B2019-12-28: $2.62B2020-12-26: $2.92B2021-12-25: $3.54B2022-12-31: $3.98B2023-12-30: $4.13B2024-12-28: $4.05B2025-12-27: $4.02B$4.02B
2008-12-27 Revenue (USD) 2025-12-27
Period endedRevenueChange YoYSource filing
2025-12-27$4.02B-0.9%2026-02-18, From 2024-12-29
2024-12-28$4.05B-1.9%2026-02-18, From 2023-12-31
2023-12-30$4.13B+3.9%2026-02-18, From 2023-01-01
2022-12-31$3.98B+12.3%2025-02-19, From 2021-12-26
2021-12-25$3.54B+21.1%2024-02-14, From 2020-12-27
2020-12-26$2.92B+11.5%2023-02-22, From 2019-12-29
2019-12-28$2.62B+15.7%2022-02-16, From 2018-12-30
2018-12-29$2.27B+22.0%2021-02-17, From 2017-12-31
2017-12-30$1.86B+10.5%2020-02-11, From 2017-01-01
2016-12-31$1.68B+23.3%2019-02-13, From 2015-12-27
2015-12-26$1.36B+5.1%2018-02-13, From 2014-12-28
2014-12-27$1.30B+11.3%2017-02-14, From 2013-12-29
2013-12-28$1.17B+3.2%2016-02-12, From 2012-12-30
2012-12-29$1.13B-1.1%2015-02-17, From 2012-01-01
2011-12-31$1.14B+0.8%2014-02-25, From 2010-12-26
2010-12-25$1.13B-3.3%2013-02-27, From 2009-12-27
2009-12-26$1.17B-9.5%2012-02-27, From 2008-12-28
2008-12-27$1.30Bn/a2011-02-23, From 2007-12-30

Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Charles River Laboratories International, Inc. (CRL)2025-12-27$4.02B-0.9%
Incyte Corp (INCY)2025-12-31$5.14B+21.2%
Medpace Holdings, Inc. (MEDP)2025-12-31$2.53B+20.0%
Icon PLC (ICLR)2025-12-31$8.25B+0.8%
Iqvia Holdings Inc. (IQV)2025-12-31$16.31B+5.9%
NRC Health (NRC)2025-12-31$137.39M-4.0%
MaxCyte, Inc. (MXCT)2025-12-31$33.03M-14.5%
OmniAb, Inc. (OABI)2025-12-31$18.67M-29.3%
Foxo Technologies Inc. (FOXO)2025-12-31$16.37M+304.0%

Compare CRL, INCY, MEDP, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗